In so heavily prioritizing one of its obligations   —    the protection of consumers   —    the F. D. A. has sometimes subordinated and neglected its other key obligation the agency’s to guide new medical innovations to market , " Dr. Gottlieb the agency’s National Affairs , a    political journal .Some of Dr. Gottlieb ’s views have alarmed researchers who argue that the agency’s study of drugs and medical devices is the best way to ensure they work .In 2014 , Dr. Dr. Gottlieb a medical device study that used " sham , " or dummy , procedures as Dr. Gottlieb placebo .